PhD in Oncology, Hematology and Pathology

Academic Year 2022-2023
Subject area Medical, Pharmaceutical and Veterinary Medical Sciences
Cycle 38
Coordinator Prof. Manuela Ferracin
Language English, Italian
Duration 3 years

Application deadline: Aug 02, 2022 at 11:59 PM (Expired)

NRRP Call for Applications

Enrolment: From Sep 30, 2022 to Oct 10, 2022 - On download NRRP forms only

Doctoral programme start date: Nov 01, 2022

NRRP loghi

Application deadline: Jun 09, 2022 at 11:59 PM (Expired)

Call for Applications

Positions: More information in the PhD Programme Table

Enrolment: From Jul 21, 2022 to Jul 31, 2022

Doctoral programme start date: Nov 01, 2022

Operating centre
Main Department
Department of Experimental, Diagnostic and Specialty Medicine - DIMES
Associated Departments
Department of Biomedical and Neuromotor Sciences - DIBINEM
Department of Medical and Surgical Sciences - DIMEC
Research topics
  • Solid and hematological neoplasms
  • Immunoprevention and immunotherapy of tumors
  • Oncology, genomics, proteomics and targeted therapy of musculoskeletal sarcomas
  • Development of new therapies, biological and cellular therapies in pediatric onco-hematology (neuroblastoma, acute myeloid leukemia, leukemias and lymphomas of B cells)
  • Radiotherapy, oncological radiodiagnostics, radiomics and radiobiology
  • Rare tumors
  • ERBB family receptors
  • Resistance to targeted therapies
  • Acute and chronic myeloproliferative syndromes
  • Lympho(immuno) proliferative diseases, monoclonal gammopathies and multiple myeloma
  • Molecular basis, genetic studies, and development of innovative and targeted drugs against adult onco-hemopathies (acute and chronic leukemias, lymphomas and multiple myeloma)
  • Molecular pathology of infections associated with implants: search of virulence factors of opportunistic microorganisms as etiologic agents of periprosthetic infections and pathogenic mechanisms
  • Cytotoxic mechanisms of plant toxic enzymes and development of immunotargeting for experimental therapy in oncology and transplant rejection
  • Alterations of protein glycosylation in pathological processes
  • Changes in ribosome biogenesis, cell proliferation and tumorigenesis
  • Immunology, genetics and epigenetics of aging, longevity and age-associated diseases
  • Allelic polymorphisms to identify risk factors associated with dementia and Alzheimer disease
  • Chronic pain
  • OMIC- data analysis
  • Genetic and epigenetic alterations as cancer diagnostic or prognostic biomarkers
  • Role of non-coding RNA in human cancer
  • Shiga toxin and hemolytic uremic syndrome
  • Human genomics and transcriptomics in normal conditions and in genetic disorders
  • Stem cells, differentiation and development
  • Nutrition, microbiota and cancer
  • Asbestos and cancer
Job opportunities and potential areas of employment
Our PhDs find employment in public and private research institutions, both national and international (mainly European and U.S.), in the healthcare system, including national research and care institutes (IRCCS) and in private laboratories and clinics.
Admission Board

NRPP Call Admission Board
Appointed by RD 1103/2022 Prot. n. 0162873 of 17/07/2022

Surname Name University / Institution Role Email
Bolognesi Andrea Università di Bologna Member
Ferracin Manuela Università di Bologna Member
Soverini Simona Università di Bologna Member
Brandi Giovanni Università di Bologna Substitute
Lauriola Mattia Università di Bologna Substitute
Masetti Riccardo Università di Bologna Substitute
Pelleri Maria Chiara Università di Bologna Substitute

Katia Scotlandi

Istituto Ortopedico Rizzoli di Bologna

Rappresentante ente esterno

Giovanni Martinelli

Istituto Romagnolo per la studio dei tumori "Dino Amadori"

Rappresentante ente esterno

Giovanni Martinelli

Istituto Romagnolo per la studio dei tumori "Dino Amadori"

Rappresentante ente esterno

Call for Application Admission Board
Appointed by RD 830/2022 Prot. n. 0127511 of 30/05/2022

Surname Name University / Institution Role email
Bolognesi Andrea Università di Bologna Member
Brandi Giovanni Università di Bologna Member
Ferracin Manuela Università di Bologna Member
Soverini Simona Università di Bologna Member
Lauriola Mattia Università di Bologna Substitute
Masetti Riccardo Università di Bologna Substitute
Pelleri Maria Chiara Università di Bologna Substitute
Learning outcomes

The students of the Ph.D. Program will develop:

  • advanced knowledge of the literature and theory in the fields of Oncology, Hematology and Pathology
  • theoretical and practical knowledge of advanced research skills
  • autonomy in producing original research of appropriate quality for publication in high-impact scholarly journals
  • skills in translational research that applies to clinical challenges the avanced knowledge originating from laboratory research.
Activities to be carried out by Doctoral candidates

The activity is largely devoted to translational and clinical research in the fields of oncology, hemathology and pathology. The activities include research in the laboratory, field research, clinical research, and the  use of large advanced equipment in the field of molecular biology and genetics. The PhD program therefore directs towards preclinical and clinical research applications and offers wide opportunities to trainees to develop their activities in centers of scientific and clinical excellence.

Research training activities compliant with the Doctoral programme's learning outcomes

The PhD program includes laboratory and/or clinical research activities, organized by the Supervisor of each PhD student, and teaching activities organized by three - The pool of medical PhD Programs organizes courses of scientific English (24 hours, in collaboration with Centro Linguistico d’Ateneo) and courses on safety in the biomedical environment (12 hours, in collaboration with the Area Persone e Organizzazione of the University and with the safety managers of the medical Departments).

The PhD program organizes seminars by faculty members. Main subjects are: Biology and pathology of the cell cycle, Cell death and apoptosis, Mechanisms of cytotoxicity of Ribosome Inactivating Proteins, Genetic variants involved in longevity or age-associated diseases, Cytokines in human disease, Glycobiology and glycopathology, Molecular and cellular oncology, Carcinogenesis, Tumor immunology and immunotherapy, Diagnosis of hematopoietic and solid tumors, Cancer epidemiology and prevention, Conventional and innovative therapy of tumors, Biopathology and treatment of lymphomas, myeloma and acute leukemias, Allogeneic/autologous stem cells transplantation, New molecular technnologies for the study of hematologic malignancies. Role of non-coding RNAs in cancer. Biopathology and treatment of sarcomas.

Each Supervisor coordinates the attendance of specific events (meetings, workshops, grand rounds, etc.) and provides advanced bioinformatical education and tools in relation to the specific research project of each PhD student.

Internationalization features
  • International experience. All Ph.D. students should attend research laboratories abroad in major research institutions, for at least 3 months.
  • Attraction of foreign graduates (Fellowships Marie Curie).
  • PhD adherence to co-tutorship agreements with University of Southern Queensland (Australia) and University of Medicine of Tirana (Albania).
  • Participation in the UNA Europa - European Program in Cultural Heritage (Una-Her) initiative.
Expected research results and products

Papers published in international journals, indexed in PubMed (at least one full paper per PhD student during the PhD course, or within 2 years after the end of PhD), and oral/poster communications at national and international scientific meetings. Also, patents resulting from translational research and clinical protocols resulting from clinical research.


Attachment 1

NRRP Call - Admission Exams Schedule

Qualifications Evaluation Results: from Aug. 25th, 2022; Oral Examination: from Sept. 8th, 2022; Oral Examination Results: from Sept. 9th, 2022. For further information, check the detail of your application on Studenti Online.